Organization Overview
Alternative names
acetaminophen (tylenol) (1 trial)
aliskiren (tekturna) (2 trials)
amlodipine (norvasc) (1 trial)
ceftolozane (Zerbaxa) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
Anemia, Iron-Deficiency (Phase 3)
Arsenic Poisoning (Phase 3)
Arthralgia (Phase 2)
Back Pain (Phase 4)
Breast Neoplasms (Phase 2)
Burns (Phase 4)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 2)
Cardiotoxicity (Phase 2)
Constipation (Phase 4)
Coronary Artery Disease (Phase 4)
Cough (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Emergencies (Phase 1)
Fibrosis (Phase 2)
Hyperkinesis (Phase 1)
Hypersensitivity (Phase 1)
Hypogonadism (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 2)
Infarction (Phase 3)
Insulin Resistance (Phase 1)
Keratosis (Phase 3)
Keratosis, Actinic (Phase 3)
Leprosy (Phase 4)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Low Back Pain (Phase 4)
Lung Diseases (Phase 2)
Lung Diseases, Interstitial (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Melanosis (Phase 3)
Multiple Sclerosis (Phase 3)
Mycoses (Phase 4)
Myocardial Infarction (Phase 3)
Neuroblastoma (Phase 1)
Nutrition Disorders (Phase 1)
Obesity (Phase 4)
Obesity, Morbid (Phase 1)
Osteoporosis (Phase 2)
Ovarian Neoplasms (Phase 2)
Pain, Postoperative (Phase 4)
Poisoning (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Pulmonary Fibrosis (Phase 2)
Respiratory Insufficiency (Phase 4)
Respiratory Tract Diseases (Phase 2)
Sclerosis (Phase 3)
Sepsis (Phase 4)
Tuberculosis (Phase 4)
Urinary Bladder, Neurogenic (Phase 3)
Vitamin D Deficiency (Phase 2)
Vomiting (Phase 1)